34682-99-0Relevant articles and documents
PYRAZOLOTRIAZINES
-
Page/Page column 249-250, (2021/06/22)
The present invention provides compounds of general formula (I), in which X, R1, R2 and R3 are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of hyperproliferative disorders such as cancer disorders, as a sole agent or in combination with other active ingredients.
PYRAZOLOPYRAZINES ACTING ON CANCERS VIA INHIBITION OF CDK12
-
Page/Page column 301, (2021/09/11)
The present invention provides compounds of general formula (I) in which X, R1, R2 and R3 are as described and defined herein, methods of preparing said compounds, intermediate compounds useful for preparing said compounds, pharmaceutical compositions and combinations comprising said compounds, and the use of said compounds for manufacturing pharmaceutical compositions for the treatment and/or prophylaxis of diseases, in particular of hyperproliferative disorders such as cancer disorders, as a sole agent or in combination with other active ingredients.
2-substituted-4-arylaminopyrazolotriazine derivative and application thereof in preparation of antitumor drugs
-
Paragraph 0071; 0072, (2020/04/17)
The invention discloses a 2-substituted-4-arylaminopyrazolotriazine derivative and application thereof in preparation of antitumor drugs. The structural general formula of the derivative is shown in the specification, wherein R1 is any one of diethylamino